ESCO Technologies Inc.

ESE · NYSE · Industrials

$284.43▼ -2.18%

$6.34 today

Mkt cap $7.77B
P/E 59.0
Day $282.16 – $289.40

Confidence

High conviction

The read

ESCO Technologies beat EPS estimates, but revenue conversion remained the key forward test

ESCO reported $2.20 EPS versus a $2.12 estimate, while shares were little changed at $300.83 three days after the print.

Confidence note: Confidence is high because reported EPS and the 3.77% surprise are available; revenue guidance and event-day price reactions were not provided.

What happened

Earnings print

Reported EPS was $2.20 versus $2.12 estimated, a $0.08 or 3.77% beat for the quarter ended June 30, 2026.

Guidance

No explicit guidance update or management guidance tone was provided in the payload.

Price reaction

The event-day and first two post-report reactions were unavailable; shares were up 0.14% to $300.83 on August 13.

Street narrative

Post-earnings intelligence emphasized backlog revenue conversion as the catalyst and slowing backlog conversion or weaker utility demand as risks.

So what

What changed

EPS was $2.20, beating the $2.12 estimate by $0.08, while backlog conversion became the key forward test.

What the market is pricing

The 0.14% move at $300.83 reflects limited immediate repricing despite a 54.87x trailing P/E.

Fundamental takeaway

Maintain a positive bias only if backlog conversion improves; the thesis weakens if utility demand or revenue delivery slows.

Next 30–90 days

Bull

40%

The EPS beat supports the growth thesis if backlog converts into revenue and utility demand remains supportive over the next 30-90 days.

The next quarterly update identifies measurable backlog-to-revenue conversion progress.
Utility demand remains supportive and revenue delivery improves from the post-earnings concern.

Base

35%

A $2.20 EPS beat may support earnings continuity, but the 65.01x sector-relative trailing valuation can limit upside without clearer revenue delivery.

The next quarterly report confirms continued earnings growth without a weaker revenue or utility-demand message.
Shares remain above the $266.21 200-day SMA while revenue-conversion evidence remains unchanged.

Bear

25%

A premium valuation leaves limited tolerance for slower backlog conversion or weaker utility demand, potentially overwhelming the recent EPS beat.

The next 30-90 days produce evidence of slowing backlog conversion or weaker utility demand.
Revenue delivery remains the central concern while the stock trades below its $316.16 20-day SMA and $319.24 50-day SMA.

What to do

If you hold it

Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.

If you're watching

Add only if next-quarter guidance is reiterated or raised; avoid if guidance is cut or geopolitical risk escalates.

Add to Watchlist

Next quarterly update: backlog revenue conversion and revenue delivery.
Utility demand commentary in the next company update.
Share position versus the $316.16 20-day and $319.24 50-day SMAs.
Valuation: 65.01x trailing P/E and 37.19x forward P/E versus sector figures of 34.3x and 24.9x.